The phase of the bacterial growth curve that shows the maximum rate of cell division is the

A. Positive-sense RNA: Positive-sense RNA viruses possess genomes that function directly as messenger RNA (mRNA). After entering the host cell, the viral RNA can immediately bind to host ribosomes and begin translation to produce viral proteins. No transcription step is required before protein synthesis, these viruses can rapidly initiate replication once infection occurs.

B. Negative-sense RNA: Negative-sense RNA viruses have genomes that are complementary to mRNA and therefore cannot be translated directly by host ribosomes. Before protein synthesis can occur, the virus must first use an RNA-dependent RNA polymerase to synthesize a complementary positive-sense RNA strand. Only this newly formed RNA can function as mRNA for protein production.

C. Double-stranded RNA: Double-stranded RNA viruses contain both a positive and a negative RNA strand. However, the host cell cannot directly translate the double-stranded genome. The virus must first use viral RNA polymerase enzymes to transcribe the negative strand into a positive-sense RNA that can serve as mRNA for translation.

A. blocks penetration: Blocking penetration prevents viruses from entering host cells. Nucleotide analogs do not interfere with viral entry; instead, they act after the virus has already penetrated the host cell.

B. inhibits peptidoglycan cross-linking: Peptidoglycan is a component of bacterial cell walls, not viruses. Antibiotics like penicillin target this process, but nucleotide analogs target viral nucleic acid synthesis, not bacterial cell walls.

C. bonds to ergosterol in the cell membrane: Binding to ergosterol is the mechanism of action for antifungal drugs such as amphotericin B. Nucleotide analogs do not interact with membranes or sterols.

D. blocks DNA replication: Nucleotide analogs resemble natural nucleotides and are incorporated into viral DNA or RNA during replication. Once incorporated, they can terminate chain elongation or cause mutations, effectively inhibiting viral DNA replication and viral proliferation.

E. blocks maturation: Blocking maturation interferes with viral assembly or processing of viral proteins, a mechanism seen with protease inhibitors. Nucleotide analogs act earlier in the replication cycle by directly targeting nucleic acid synthesis rather than late-stage viral maturation.